Vapotherm Inc.
Vapotherm Inc. is listed today as Vapotherm: market value, financials and filings are on its company page.
Funding rounds
6 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Sep 2018 | $10 M | No. 6 | $10 to $50 million | equity | SEC | |
| May 2017 | $20 M | No. 5 | $10 to $50 million | equity | SEC | |
| Oct 2015 | $15 M | No. 4 | $10 to $50 million | equity | SEC | |
| Mar 2015 | $20 M | No. 3 | $10 to $50 million | equity | SEC | |
| Feb 2014 | $24 M | No. 2 | $10 to $50 million | equity | SEC | |
| Mar 2013 | $26 M | No. 1 | $10 to $50 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Vapotherm Inc. chose not to state its revenue in its newest notice of a funding round (Oct 2018).
SEC Form D · Oct 2018
The industry group it chose in its notices: Other Health Care.
SEC Form D · Oct 2018
That is all the official record says: Vapotherm Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services of Vapotherm Inc. are on record.
Investors#
15 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| 3x5 Partners, LLC | Fund or asset manager | not stated | not stated | Held Series A, B, C, D and D-1 preferred stock, 10% owner (Form 3, 2020) | SEC Form 3 |
| 3x5 Special Opportunity Fund, L.P. | Fund or asset manager | not stated | not stated | Held Series A, B and C preferred stock, 10% owner (Form 3, 2018) | SEC Form 3 |
| Gilde Healthcare Holding B.V. | Other | not stated | not stated | Held Series B, C and D preferred stock, 10% owner (Form 3, 2018) | SEC Form 3 |
| John Coolidge | Person | not stated | not stated | Held Series A and C preferred stock (Form 3, 2018) | SEC Form 3 |
| John Landry | Person | not stated | not stated | Held Series A and C preferred stock (Form 3, 2018) | SEC Form 3 |
| Joseph Army | Person | not stated | not stated | Held Series A and C preferred stock, director (Form 3, 2018) | SEC Form 3 |
| Morgenthaler Management Partners IX, LLC | Fund or asset manager | not stated | not stated | Held Series A, B, C, D and D-1 preferred stock, 10% owner (Form 3, 2018) | SEC Form 3 |
| Morgenthaler Venture Partners IX LP | Venture capital | not stated | not stated | Held Series A, B, C, D and D-1 preferred stock, 10% owner (Form 3, 2018) | SEC Form 3 |
| Redmile Group, LLC | Fund or asset manager | not stated | not stated | Held Series D and D-1 preferred stock, 10% owner (Form 3, 2018) | SEC Form 3 |
| SightLine Healthcare Opportunity Fund II-A, L.P. | Fund or asset manager | not stated | not stated | Held Series A, B, C and D preferred stock, 10% owner (Form 3, 2018) | SEC Form 3 |
| SightLine Healthcare Opportunity Fund II-B, L.P. | Fund or asset manager | not stated | not stated | Held Series A, B, C and D preferred stock, 10% owner (Form 3, 2018) | SEC Form 3 |
| SightLine Healthcare Opportunity Fund II, L.P. | Fund or asset manager | not stated | not stated | Held Series A, B, C and D preferred stock, 10% owner (Form 3, 2018) | SEC Form 3 |
| SightLine Investors LLC | Fund or asset manager | not stated | not stated | Held Series A, B, C and D preferred stock, 10% owner (Form 3, 2018) | SEC Form 3 |
| SightLine Partners LLC | Fund or asset manager | not stated | not stated | Held Series A, B, C and D preferred stock, 10% owner (Form 3, 2018) | SEC Form 3 |
| Vapotherm Investors, LLC | Fund or asset manager | not stated | not stated | Held Series A, B, C, D and D-1 preferred stock, 10% owner (Form 3, 2020) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 6 rounds above had up to 20 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| David B. Blouin | Executive officer | Oct 2018 |
| George Dungan Ii | Executive officer | Oct 2018 |
| Greg B. Ramade | Executive officer | Oct 2018 |
| Jill B. Dooling | Executive officer | Oct 2018 |
| John Coolidge | Executive officer | Oct 2018 |
| John Landry | Executive officer | Oct 2018 |
| Joseph Army | Executive officer | Oct 2018 |
| Lindsay B. Becker | Executive officer | Oct 2018 |
| Lise Halpern | Executive officer | Oct 2018 |
| Marc B. Davidson | Executive officer | Oct 2018 |
| Richelle B. Helman | Executive officer | Oct 2018 |
| Buck B. Weller | Executive officer | May 2017 |
| George B. Dungan | Executive officer | May 2017 |
| Gregoire B. Ramade | Executive officer | May 2017 |
| John B. Coolidge | Executive officer | May 2017 |
| Lise B. Halpern | Executive officer | May 2017 |
| Michael B. Webb | Executive officer | May 2017 |
| Som B. Kovvuri | Executive officer | May 2017 |
| Kevin B. Thibodeau | Executive officer | Dec 2015 |
| Anthony B. Arnerich | Director | Oct 2018 |
| Craig B. Reynolds | Director | Oct 2018 |
| Elizabeth B. Weatherman | Director | Oct 2018 |
| Geoff J. Pardo | Director | Oct 2018 |
| J. Neal Armstrong | Director | Oct 2018 |
| James W. Liken | Director | Oct 2018 |
| Jason B. Lettman | Director | Oct 2018 |
| Joseph Army | Director | Oct 2018 |
| Marina B. Hahn | Director | Oct 2018 |
| Michael J. Ward | Director | Oct 2018 |
| Sam B. Brasch | Director | Oct 2018 |
| James Neal Armstrong | Director | May 2017 |
| Samuel J. Brasch | Director | Apr 2014 |
About
Medical device manufacturer.